<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20181105041563N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-12-05</date_registration>
      <primary_sponsor>Vice chancellor for research, Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>Comparative of the effect of Aloe Vera Gel and Sildenaﬁl ointment on Pressure ulcers in stage II</public_title>
      <acronym></acronym>
      <scientific_title>Comparative evaluation of the effect of Aloe Vera Gel and Sildenaﬁl ointment on Pressure ulcers in stage II</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-12-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/35480</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Qualified samples were entered into the study by accessible method and randomly divided into intervention groups (Aloe Vera Gel, sildenafil Ointment and Combination of Aloe Vera Gel and Sildenafil Ointment) and control. Blocks were done as follows: To dressing groups with Aloe Vera Gel, sildenafil Ointment and Combination of Aloe Vera Gel and Sildenafil Ointment  was assigned  A ، B and C codes respectively, and the control group received D code. The study blocks were ABCD, ABDC, ACBD, ACDB, ADBC, ADCB, and the ABCD block was selected as the first block. Patients were assigned to Aloe Vera Gel, sildenafil Ointment ,Combination of Aloe Vera Gel and Sildenafil Ointment , and control groups, respectively, and this method continued until the samples were completed.</study_design>
      <phase>2-3</phase>
      <hc_freetext>pressure ulcer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In group 1, the wound will be dressed daily at 8:00 AM with Aloe Vera gel (94%) for 30 days, and will be checked on the days of 1,3,7,14,21,30 by push scale. The brand of this product is Aloe Vera gel and its scientific name Aloe barbadensis Miller. This herb is used as a gel and has antimicrobial and antioxidant effects, increased moisture, anti-inflammatory effects, inhibited thromboxane (an ulcer healing inhibitor), and increased blood flow to the wound site. Intervention 2: In group 2, the ulcer will be dressed with sildenafil citrate (. 3%) ointment for 8 days, and will be dressed for 30 days, and will be checked in push-scale on days 1,3,7,14,21,30.The brands of this ointment are Viagra and Revatio. It has nitric oxide compounds, which have been shown to be effective in wound healing. These compounds stimulate cell proliferation, stimulate the activity of fibroblasts, collagen release, antimicrobial effect, antifungal, angiogenesis, increased blood flow to the site of injury and increase the secretion of the growth factor. Intervention 3: In group 3, the ulcer, at 8 o'clock in the morning, with a combination of sildenafil citrate ointment(. 3%)  and Aloe Vera gel (94%) will be dressed in a 3: 2 ratio for 30 days and will be examined by push-scale on days 1,3,7,14,21,30. Intervention 4: Control group: In group 4, the ulcer, up to 30 days, every two days, at 8 o'clock, will be dressed with Hydrocolloid(Comfeel) and will be checked by push-scale on 1,3,7,14,21,30 days.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no specific program for publishing this project currently .</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Somayeh Mahdavikian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing Department, Kermanshah School of Nursing and Midwifery, Ashayer Blv., Kermanshah, Iran</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6715986479</zip>
        <telephone>+98 83 3816 2560</telephone>
        <email>Somayeh.Mahdavikian@kums.ac.ir</email>
        <affiliation>Kermanshah School of Nursing and Midwifery</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Somayeh Mahdavikian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing Department, Kermanshah School of Nursing and Midwifery, Ashayer Blv., Kermanshah, Iran</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6715986479</zip>
        <telephone>+98 83 3816 2560</telephone>
        <email>Somayeh.Mahdavikian@kums.ac.ir</email>
        <affiliation>Kermanshah School of Nursing and Midwifery</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Consent of the physician and the patient to participate in the study
Insensitivity to Aloe vera and sildenafil
The absence of any signs of wound infection
skin disease,
having aged over 18 years
stage 2 of  Starling scale
Lack of bleeding
earn points equal to 14-6 from Braden scale
no addiction to drugs and alcohol
no diabetes, and kidney failure</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Reduction of platelets and hemoglobin
need for debridement
reluctance to continue cooperation
need for any surgery
bleeding
death</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>L89.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stage II decubitus ulcer</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In group 1, the wound will be dressed daily at 8:00 AM with Aloe Vera gel (94%) for 30 days, and will be checked on the days of 1,3,7,14,21,30 by push scale. The brand of this product is Aloe Vera gel and its scientific name Aloe barbadensis Miller. This herb is used as a gel and has antimicrobial and antioxidant effects, increased moisture, anti-inflammatory effects, inhibited thromboxane (an ulcer healing inhibitor), and increased blood flow to the wound site.</i_keyword>
      <i_keyword>In group 2, the ulcer will be dressed with sildenafil citrate (. 3%) ointment for 8 days, and will be dressed for 30 days, and will be checked in push-scale on days 1,3,7,14,21,30.The brands of this ointment are Viagra and Revatio. It has nitric oxide compounds, which have been shown to be effective in wound healing. These compounds stimulate cell proliferation, stimulate the activity of fibroblasts, collagen release, antimicrobial effect, antifungal, angiogenesis, increased blood flow to the site of injury and increase the secretion of the growth factor.</i_keyword>
      <i_keyword>In group 3, the ulcer, at 8 o'clock in the morning, with a combination of sildenafil citrate ointment(. 3%)  and Aloe Vera gel (94%) will be dressed in a 3: 2 ratio for 30 days and will be examined by push-scale on days 1,3,7,14,21,30.</i_keyword>
      <i_keyword>Control group: In group 4, the ulcer, up to 30 days, every two days, at 8 o'clock, will be dressed with Hydrocolloid(Comfeel) and will be checked by push-scale on 1,3,7,14,21,30 days</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Healing of pressure ulcer. Timepoint: Day one, three, seven, fourteen, twenty one and thirty of the study. Method of measurement: push scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research, Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-06-14</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Kermanshah University of Medical Sciences, Shahid Beheshty Blv, Kermanshah University of Medical Sciences, Kermanshah, Iran Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
